Jia Luo, MD
@Jia_Luo
@DanaFarber @harvardmed thoracic medical oncologist and cancer researcher // Prev MSKCC Fellow, OHSU IM & Chief Res, Stanford Med, and UW-Madison #GlobalCook
ID:308338117
https://www.dropbox.com/s/diiz6mc4sr4ek0b/JL%20disclosures.docx?dl=0 31-05-2011 07:15:38
869 Tweets
931 Followers
397 Following
Happy to share my new interactive article / explorable on K-Means Clustering, which has also been accepted to VISxAI at IEEE VIS!
k-means-explorable.vercel.app
Built with #svelte and #d3js .
#MachineLearning #DataScience #Datavisualization #dataviz #scicomm
Thank you Nature Cancer for reviewing our study nature.com/articles/s4301… demonstrating multimodal data integration increases capacity to predict ICB response in non-small cell lung cancer. Terrific work led by Rami Vanguri Jennifer Sauter, MD Jia Luo, MD and many others. 1/8
#Biomarker results can be confusing & difficult to understand for patients & their families. Check out the new LUNGevity Foundation “Reading a Biomarker Testing Report” created in partnership with ACCC Association for Molecular Pathology IASLC & APSHO for help. #LCSM
tinyurl.com/2nxx87rh
💫NEW in Nature Cancer:
Multimodal integration of #radiology #pathology and #genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell #lungcancer by Sohrab Shah Jennifer Sauter, MD & co Memorial Sloan Kettering Cancer Center #NSCLC #immunotherapy
👇🏻
nature.com/articles/s4301…
A recent report based on a symposium sponsored by Dana-Farber calls for new measures to address NUT carcinoma, including new clinical trials for patients with this rare and devastating cancer. blog.dana-farber.org/insight/2022/0…
Which pts with SD from ICIs are ‘responders’(have similar outcomes to those w PR/CR)?
- systemic rev 59 ICI trials comparing SD pts to those w PR/CR v PD by BOR &PFS
- pts w PFS >6mo+no tumor growth, similar to those w PR
Annals of Oncology Jia Luo, MD
sciencedirect.com/science/articl…
Fabulous evening meeting wonderful colleagues in the DC area - thank you for hosting Stephen V Liu, MD!
Thank you to all faculty - esp Bruce, Keith, Ross Levine, Michael Postow, Bernardo, Ryan, Tatiana Prowell, MD - for sharing their time & wisdom with us!
Awesome colleagues and timely/ high-yield early career workshop spanning the spectrum of translational research
On this #WorldLungCancerDay don't forget to watch our most recent #LungCancer session with Jia Luo, MD and Julia Rotow MD (@DanaFarber) who discuss learnings from #ASCO22
Watch here: ow.ly/NNfQ50K8PwJ
#LungCancer #LCsm ASCO
A stellar academic med Gurpreet Dhaliwal must-read for July --- 'The Greatest Generation' on professionalism, fostering a culture of respect, and the growth mindset
jamanetwork.com/journals/jama/… ht Dr AngelaLam
Multiple driver alterations are drug targets in advanced NSCLC 🫁. With the emergence of allele-specific KRAS inhibitors, @jia_luo and coll. investigate clinicopathologic, genomic, & immunophenotypic characteristics of NSCLC with KRAS G12D mutations
#LCSM
annalsofoncology.org/article/S0923-…